Trial intelligence / Profile preview

Median effective concentration of propofol with different doses of esketamine during gastrointestinal endoscopy in elderly patients

ChiCTR2100042252Phase 4Recruiting

Sponsor
Shidong Hospital
Start
Feb 2021
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of propofol and esketamine in None (3 arms), sponsored by Shidong Hospital. Primary endpoints: Blood pressure and Heart rate. Started Feb 2021; status: recruiting.

02

Drugs

propofolesketamine

Beyond the preview

Go deeper on ChiCTR2100042252.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2100042252.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call